Skip to main content

3 weeks ago

Open Basic Science T32 Postdoctoral Research Positions

Join an established interdisciplinary postdoctoral T32 fellowship program in basic and translational aspects of genetics, molecular biology, immunology, microbiology, pathophysiology and treatment of liver and gastrointestinal tract disorders. Program goals are to attract Ph.D., M.D. and DVM postdoctoral trainees to these fields and to provide training in state-of-the-art research techniques. Fellowships are for two years, and are funded by an NIH (NIDDK) Institutional T32 Training Grant.

diverse scientist in lab setting

3 weeks ago

Innovate Carolina: Forward Focus (FY2021-22)

Links to impact report. UNC Inventions include therapeutics, research tools/methods, biomarkers/diagnostics, drug delivery, imaging, and much more. Congruent with Carolina’s research pipeline that is focused heavily on biomedical endeavors, the majority of its licenses are in the life sciences sector. 36 % of licenses were related to tangible property (research tools, including mice, cell lines, and antibodies). The Innovation Hub and Downtown District coming soon.

Zhichuan Zhu

2 months ago

Researchers publish in Advanced Science: Innate immunity-independent STING function is identified as a vulnerability in kidney cancer

First author postdoc Zhichuan Zhu PhD, Liu lab, Jean Cook, and collaborators publish in Advanced Science available online Nov. 29, 2022 "STING Suppresses Mitochondrial VDAC2 to Govern RCC Growth Independent of Innate Immunity." STING was identified in 2008 as a critical innate immune sensor to antagonize viral/bacterial infection. Inactivation of STING especially by epigenetic silencing has been shown to facilitate tumor progression. Efforts from various UNC and BCBP labs have recently identified an innate immunity-independent function of STING in kidney cancer that can be explored as a potential therapeutic target in treating kidney cancer...